Evaluation and Diagnosis of Underactive Bladder
Fig. 2.1 Massively distended bladder with bilateral hydronephrosis Signs of UAB UAB may exist without any of the symptoms described above. In this instance, the patient may have lost the…
Public Health and Advocacy for UAB
Fig. 14.1 Underactive bladder (UAB) may affect an individual in a variety of ways. Some of the potential impacts of UAB include urinary retention, pain/discomfort, incontinence, urinary tract infections (infection),…
Epidemiology and Demographics of Underactive Bladder
Fig. 1.1 Prevalence of self-reported difficulty emptying bladder by gender and age (Permission obtained Valente et al. 2014) A number of coexisting conditions have been implicated in UAB development and…
Advance Technology
Fig. 10.1 The inFlow Intraurethral device in proper position in this drawing cross-sectional area of a woman’s pelvis The inFlow device with activator is indicated for use “in female patients…
Diabetes and Other Neurogenic Underactive Bladder Conditions
Patients UAB criteria UAB % Predictors Kaplan et al. (1995) 115 M, 68 F, between 48 and 93 years old, with voiding symptoms Impaired detrusor contractility: poorly sustained or…
Novel Drugs for Underactive Bladder
Fig. 7.1 Potential new drugs for UAB target key molecular pathways involved in micturition control at the levels of the urothelium, detrusor muscle autonomic and afferent pathways, spinal cord, and…
Geriatric Urology and Underactive Bladder
Comorbid condition Direct and indirect effects Benign prostatic hyperplasia (BPH) Bladder outlet obstruction Cognitive impairment (delirium, dementia) Decreased sensation of filling Reduced awareness of need to void Diabetes mellitus Decreased…
Current Drug Therapy for Underactive Bladder
Fig. 6.1 Direct (bethanechol) and indirect (distigmine) agonist treatment of underactive bladder Current approaches toward medical treatment of UAB aim at providing additional stimulation of bladder muscarinic receptors. This can…
The Role of STD Pathogens in Bacterial Prostatitis
Fig. 11.1 An intermediate body of Chlamydia trachomatis undergoing differentiation. In this figure there are two points of condensation of DNA into electron-dense nucleoids (n). Note the inner cytoplasmic membrane…
Management of Infective Complications Following Prostate Biopsy
Acronym Clinical diagnosis Clinical symptoms Grade of severity CY-1 Cystitis Dysuria, frequency, urgency, suprapubic pain; sometimes unspecific symptoms 1 PN-2 Mild and moderate pyelonephritis Fever, flank pain, CVA tenderness; sometimes…
